GENZYME - THE KING OF THE BIOTECHS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: H. Bradley Toland, Jr. who wrote (265)	3/17/1998 12:47:00 PM
From: aliveinsf	Read Replies (1) of 410

GENZ UNDERPERFORMS RELATIVE TO AMGN BGEN What long term chart are you looking at? Lets take a long term view of GENZ.. On 12/31/91 GENZ was at 29.375; AMGN was at 38 and BGEN was at 20. Where are these stocks today? GENZ is up a whopping 8.9% to 32, while AMGN is up 58.9% at 60.1875 and BGEN is up 130% to 46.125. Given the rise in the general market these stocks as a group have underperformed the market, but GENZ has underperformed the underperforming group. I stand by my statements...GENZ has not returned or built much if any shareholder value for its shareholders for the past 7 years. Doesn't say much when you deliver 1.2% annual compounded growth over a 7 year period, even passbook savings accounts would have been a better investment than this DOG.... As a CEO Henri needs to hang his head in shame....time for a shareholders revolt...oust management...they are entrenched....and need to be changed....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next